Graham Capital Management’s Veracyte VCYT Stock Holding History

Graham Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$457K	Buy	14,180 +863	+6%	+$31.9K	0.01%	658
2025 Q4	$561K	Buy	+13,317	New	+$537K	0.01%	586
2025 Q3	–	Sell	-17,686	Closed	-$478K	–	1669
2025 Q2	$478K	Sell	17,686 -10,677	-38%	-$309K	0.01%	844
2025 Q1	$841K	Buy	28,363 +6,576	+30%	+$251K	0.01%	608
2024 Q4	$863K	Buy	21,787 +4,216	+24%	+$160K	0.01%	539
2024 Q3	$598K	Buy	+17,571	New	+$494K	0.01%	596
2024 Q2	–	Sell	-42,490	Closed	-$942K	–	1388
2024 Q1	$942K	Buy	42,490 +12,360	+41%	+$302K	0.02%	444
2023 Q4	$829K	Buy	30,130 +3,944	+15%	+$95.2K	0.02%	434
2023 Q3	$585K	Buy	+26,186	New	+$673K	0.01%	519
2022 Q4	–	Sell	-25,216	Closed	-$418K	–	1364
2022 Q3	$418K	Buy	+25,216	New	+$567K	0.02%	801

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Graham Capital Management's VCYT Position: Q1 2026 in Review

Graham Capital Management increased its Veracyte (VCYT) stake by 6.5% in Q1 2026, buying an estimated $31.9K and bringing the position to 14,180 shares worth $457K. The position accounts for 0.01% of the portfolio, ranked #658.

Graham Capital Management first reported a position in VCYT in Q3 2022 and has held it in 10 quarters since. The position peaked at $942K in Q1 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Graham Capital Management held 14,180 shares of Veracyte worth $457K as of Q1 2026.
Graham Capital Management bought 863 Veracyte shares in Q1 2026, an estimated $31.9K.
Veracyte made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #658 holding.
Graham Capital Management first reported a position in Veracyte in Q3 2022 and has held it in 10 quarters since.
Graham Capital Management's Veracyte position peaked at $942K in Q1 2024.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.